Clinical Trial Update: Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of an insulin-sensitizing anti-inflammatory small molecule for Alzheimer's disease has completed and results were posted on 2024-07-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Neurological Associates of West Los Angeles | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-07-09